In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
106 News Items found
Harini Veeraraghavan stands in front of a radiology display
How MSK Doctors Are Using AI To Improve Radiation Treatment

MSK researchers are leading the development of new artificial intelligence (AI) models to improve the targeting of radiation therapy — teaching computers to better isolate tumors and spare more of the surrounding healthy tissue.
Tumor mutation model
Finding
Tumor Mutational Burden Can Help Predict Response to Immunotherapy in Many Different Cancers

Investigators confirmed that people whose tumors have a high tumor mutational burden and were treated with immunotherapy lived longer.
John Mendelsohn
Feature
Remembering John Mendelsohn, a Pioneer of Targeted Therapy for Cancer

The scientific world lost one of its greats this week. Here, we reflect on his influence.
Nadeem Riaz and Timothy Chan
Finding
Gene Discovery Could Lead to More-Personalized Treatment with Immunotherapy

Researchers have found two gene mutations that many exceptional responders to ipilimumab have in common.
Breast cancer mosaic
Snapshot
New Technology Could Enable Immediate Detection of Tumor Borders during Surgery

Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries.
Dr. Debyani Chakravarty
Why New Precision Oncology Cancer Treatments Benefit Patients of Some Ancestries More Than Others

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ancestries, according to new MSK research. This trend could exacerbate disparities in cancer outcomes.
MSK urologic surgeon Timothy Donahue
In the Clinic
New Imaging Technique Could Reduce Side Effects of Prostate Cancer Surgery

Learn how a new imaging approach lights up nerves so they can be avoided during prostate cancer surgery.
Dr. Alexander Drilon
Targeted Drug Selpercatinib Greatly Reduces Risk of Recurrence in Early-Stage Lung Cancer

A clinical trial led by an MSK researcher found that the targeted therapy selpercatinib reduces the risk of recurrence by more than 80% for patients with early-stage non-small cell lung cancers carrying a RET gene fusion.
Group of racially diverse boys and girls lying on grass and conversing.
Support
Four Things Parents Should Know about the HPV Vaccine

Vaccinating children against the human papillomavirus can protect them from developing many types of cancer. Here’s what you need to know.
Scans of Immunotherapy performed on tumors
In the Clinic
Case Study Gives Hope for a Clinical Trial Testing Immunotherapy for Aggressive Pituitary Tumors

Summary A woman with an aggressive pituitary tumor responded well to immunotherapy. This successful treatment may lead to a clinical trial testing...